Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

First-trimester screening for aneuploidy: research of standard of care?

Article Abstract:

Further research is needed before doctors begin testing pregnant women for Down's syndrome in their baby in the first trimester. Many doctors believe it is best to detect Down syndrome as early as possible, they must first identify the most accurate test.

Author: D'Alton, Mary E., Malone, Fergal D., Berkowitz, Richard L., Canick, Jacob A.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
Innovations, Medical screening, Health screening, Down syndrome

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study

Article Abstract:

The risk of adverse outcome for pregnancies, with first-trimester threatened abortion, due to first-trimester vaginal bleeding, occurring in 16 to 25 percent of all pregnancies, is discussed. Various outcomes of the first-trimester bleeding during pregnancy include the pregnancy loss, preterm delivery, intrauterine growth restriction (IUGR), gestational hypertension, preeclampsia, preterm premature rupture of membranes (PPROM), placental abruption, placenta previa, and cesarean delivery.

Author: D'Alton, Mary E., Malone, Fergal D., Berkowitz, Richard L., Timor-Tritsch, Ilan E., Nyberg, David A., Dugoff, Lorraine, Weiss, Joshua L., Vidaver, John, Ball, Robert H., Gross, Susan J., Hanskins, Gary D., Comstock, Christine H.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2004
Science & research, Research, Patient outcomes, Risk factors, Pregnancy, Abortion, Abruptio placentae, Placental abruption

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-base screening study (the FASTER trial)

Article Abstract:

A study was undertaken to determine whether maternal serum levels of pregnancy-associated plasma protein A, free-beta subunit human chorionic gonadotropin, or nuchal translucency size are associated with obstetric complications. Results show that low free-beta subunit human gonadotropin levels and large nuchal translucency could result in early fetal loss.

Author: D'Alton, Mary E., Malone, Fergal D., Berkowitz, Richard L., Hobbins, John C., Dugoff, Lorraine, Vidaver, John, Comstock, Christine H., Craigo, Sabrina D., Timor-Tritsch, Illan E., Porter, Flint T., Luthy, David, Merkatz, Irwin, Hankins, Gary, Carr, Steven R., Wolfe, Honor M
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2004
United States, Analysis, Causes of, Pregnancy, Complications of, Pregnancy complications, Miscarriage, Human chorionic gonadotropin test

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Diagnosis
Similar abstracts:
  • Abstracts: The effect of dietary trans alpha-linolenic acid on plasma lipids and platelet fatty acid composition: The TransLinE study
  • Abstracts: Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome
  • Abstracts: Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda
  • Abstracts: Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument
  • Abstracts: Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. Growth hormone for the elderly?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.